MSF drags Pfizer to court in India over patent on high-cost Gavi-funded vaccine

News November 24, 2017

The medical humanitarian aid organisation Médecins Sans Frontières has taken the Indian Patent Office to court over a patent it recently granted to Pfizer for the pneumonia vaccine, Prevenar 13. MSF argues that the patent will stifle competition, blocking the development of cheaper, generic versions of the vaccine.

Leena Menghaney, Lawyer for MSF in India.
Photo: MSF Access Campaign

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.

MSF drags Pfizer to court in India over patent on high-cost Gavi-funded vaccine

Tags: